Xenon Pharmaceuticals develops clinical-stage therapeutics targeting neurological disorders, including XEN496 and XEN1101 for epilepsy and related conditions. The company operates a research-driven ...

Connecticut-based Braidwell disclosed a sale of 1,779,953 shares of Xenon Pharmaceuticals (NASDAQ:XENE) in its February 17, 2026, SEC filing, an estimated $74.76 million trade based on quarterly ...

Gui Santos delivered the game-winning bucket that sealed the Golden State Warriors’ 114-113 comeback victory over the Memphis Grizzlies on Monday night. After trailing by as many as 17 points, Golden ...

After more than a year of scattered leaks and rumors, Apple’s home hub may finally hit the market in 2026. A new report suggests the device could launch in the coming months and sheds some light on ...

WHEELING, W.Va. — With temperatures dropping and expected to remain low throughout much of January, the Life Hub in Wheeling is expanding its hours to support the homeless. Until further notice, the ...

The Chinese yuan is making gains against the US dollar and Russian ruble in Central Asia's foreign exchange markets, particularly in Kazakhstan, though the US dollar remains the dominant currency.

Two Chinese entities – the Shanghai Institute of Mechanical and Electrical Engineering and Shanghai Electric Group – have been selected as suppliers for Kazakhstan’s largest renewable energy project, ...

Xenon Pharmaceuticals is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder treatment. XENE's $555M cash position supports operations into 2027, reducing near ...

Never miss a story with The Brief, our free newsletter. Keep tabs on Texas politics and policy with our morning newsletter. The Texas Tribune Independent news. Trusted by Texans. About The Texas ...